Cite
HARVARD Citation
Timms, K. et al. (n.d.). 466 Next generation sequencing of BRCA1 and BRCA2 genes in ovarian tumors captures all germline mutations and expands the potential treatment group for the PARP inhibitor olaparib. European journal of cancer. pp. S100-S101. [Online].